ABBV210.39-0.18%
ABBV · US
1y range: 197.38 → 236.19 · as of 2026-05-15
Next earnings
2026-07-29
in 71d
Recent material news
- A Look At AbbVie (ABBV) Valuation After New Immunology Data And Upgraded 2026 Earnings Outlook2026-05-13T08:15
- The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the Beat2026-05-02T12:45
- AbbVie Files Application With FDA For Upadacitinib To Treat Adults, Adolescents With Severe Alopecia Areata2026-04-28T08:03
- AbbVie Announces Topline Results From The Phase 3B/4 Head-to-Head Select-Switch Study Evaluating The Efficacy And Safety Of Upadacitinib2026-04-28T07:10
Want this depth on every stock you watch?
ThickerPeek writes a daily AI digest on 165+ stocks, weekly theses, earnings briefings, and alerts — for €19/mo. Free tier available.
Not investment advice. ThickerPeek is a research tool. AI-written content is informational, not a buy/sell recommendation. Investment decisions are your own responsibility.